Pharmaceutical attention in the treatment of obesity involving analogues of Glucagon-like peptide 1 (GPL-1). Research, Society and Development, [S. l.], v. 11, n. 7, p. e41011730134, 2022. DOI: 10.33448/rsd-v11i7.30134. Disponível em: https://rsdjournal.org/rsd/article/view/30134. Acesso em: 5 dec. 2025.